NPHC
Nutra Pharma Corp
Price:  
0.00 
USD
Volume:  
128,010.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NPHC WACC - Weighted Average Cost of Capital

The WACC of Nutra Pharma Corp (NPHC) is 6.1%.

The Cost of Equity of Nutra Pharma Corp (NPHC) is 28.60%.
The Cost of Debt of Nutra Pharma Corp (NPHC) is 5.50%.

Range Selected
Cost of equity 14.40% - 42.80% 28.60%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 7.00% 5.50%
WACC 3.9% - 8.3% 6.1%
WACC

NPHC WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 2.3 6.78
Additional risk adjustments 0.0% 0.5%
Cost of equity 14.40% 42.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 10.95 10.95
Cost of debt 4.00% 7.00%
After-tax WACC 3.9% 8.3%
Selected WACC 6.1%

NPHC's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for NPHC:

cost_of_equity (28.60%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (2.3) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.